Corrigendum to "Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma" [J Hepatol 49 (2008) 557-563] (DOI:10.1016/j.jhep.2008.06.025);Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma

Journal of Hepatology

Volumn 49, Issue 4, 2008, Pages 557-563

  La Mura, Vincenzo ^a   Renzo, Amalia De ^b   Perna, Fabiana ^b   D'Agostino, Diego ^b   Masarone, Mario ^a   Romano, Marco ^a   Bruno, Savino ^c   Torella, Roberto ^a   Persico, Marcello ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

Hepatitis C antiviral therapy; Non Hodgkin's lymphoma

Indexed keywords

ANTIINFECTIVE AGENT; INTERFERON; RIBAVIRIN;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PREVALENCE; PRIORITY JOURNAL; TREATMENT RESPONSE;

EID: 50549089101     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.12.009     Document Type: Erratum

References (26)

1. Agnello V., and De Rosa M.G. Extrahepatic manifestations of HCV infection: some current issues. J Hepatol 40 (2004) 341-352
2. Musto P. Hepatitis C virus and B-cell Non Hodjkin's lymphomas: more than a simple association. Clin Lymphoma 3 (2002) 150-160
3. Morgensztern D., Rosado M., Silva O., Santos E., Abdullah S., Goodman M., et al. Prevalence of hepatitis C infection in patients with non-Hodgkin's lymphoma in South Florida and review of the literature. Leuk Lymphoma 45 (2004) 2459-2464
4. Nieters A., Kallinowski B., Brennan P., Ott M., Maynadié M., Benavente Y., et al. Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH. Gastroenterology 131 (2006) 1879-1886
5. De Vita S., De Re V., Sansonno D., Gloghini A., Gasparotto D., Libra M., et al. Lack of HCV infection in malignat cells refutes the hypothesis of a direct transforming action of the virus in the pathogenesis of HCV-associated B-cell NHLs. Tumori 88 (2002) 400-406
6. Persico M., Capasso M., Persico E., Masarone M., De Renzo A., Spano D., et al. Interleukin-10-1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection. J Hepatol 45 (2006) 779-785
7. Negri E., Little D., Baiocchi M., La Vecchia C., and Franceschi S. B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review. Int J Cancer 10 (2004) 1-8
8. Matsuo K., Kusano A., Sugumar A., Nakamura S., Tajima K., and Mueller N.E. Effect of hepatitis C virus infection on the risk of non-Hodjkin's lymphoma: a meta analysis of epidemiological studies. Cancer Sci 95 (2004) 745-752
9. Kawamura Y., Ikeda K., Arase Y., Yatsuji H., Sezaki H., Hosaka T., et al. Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C. Am J Med 120 (2007) 1034-1041
10. Matsuo K., Kusano A., Sugumar A., Nakamura S., Tajima K., and Mueller N.E. Peg-interferon alfa 2b plus ribavirin compared with interferon-alfa 2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 358 (2001) 958-965
11. Hermine O., Lefrère F., Bronowicki J.P., Mariette X., Jondeau K., Eclache-Saudreau V., et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 347 (2002) 89-94
12. Vallisa D., Bernuzzi P., Arcaini L., Sacchi S., Callea V., Marasca R., et al. Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, Non-Hodjkin's lymphoma: a multicenter italian experience. J Clin Oncol 23 (2005) 468-473
13. Fisher R.I., Gaynor E.R., Dahlberg S., Oken M.M., Grogan T.M., Mize E.M., et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced Non-Hodgkin's Lymphoma. N Engl J Med 328 (1993) 1002-1006
14. Coiffier B., Lepage E., Brière J., Herbrecht R., Tilly H., Bouabdallah R., et al. CHOP chemotherapy plus Rituximab compared with CHOP alone in elderly patients with diffuse large-b-cell lymphoma. N Engl J Med 346 (2002) 235-242
15. Brice P., Bastion Y., Lepage E., Brousse N., Haioun C., Moreau P., et al. Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 15 (1997) 1110-1117
16. Cheson B.D. What is new in lymphoma?. CA A Cancer J Clin 54 (2004) 260-272
17. Mele A., Pulsioni A., Bianco E., Musto P., Szklo A., San Paolo M.G., et al. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multiceter case-control study. Blood 103 (2003) 996-999
18. De Rosa G., Gobbo M.L., De Renzo A., Notaro R., Garofalo S., Grimaldi M., et al. Prevalence of Hepatitis C Virus infection in patients with B-cell lymphoproliferative disorders in Italy. Am J Hematol 55 (1997) 77-82
19. Alisi A., Giannini C., Spaziani A., Caini P., Zignego A.L., and Balsano C. Involvement of PI·K in HCV-related lymphoproliferative disorders. J Cell Physiol 214 (2008) 396-404
20. Ishikawa T., Shibuya K., Yasui K., Mitamura K., and Ueda S. Expression of hepatitis C virus core protein associated with malignant lymphoma in transgenic mice. Comp Immunol Microbiol Infect Dis 26 (2003) 115-124
21. Zignego A., Giannini C., and Ferri C. Hepatitis C virus-related lymphoproliferative disorders: an overview. World J Gastroenterol 13 (2007) 2467-2478
22. Tomita N., Kodama F., Takabayashi M., Kawano T., Yamaji S., Fujimaki K., et al. Clinical features and outcome in HCV-positive aggressive non-Hodgkin's lymphoma. Leuk Lymphoma 44 (2003) 1159-1164
23. Zignego A.L., Ferri C., Giannelli F., Giannini C., Caini P., Monti M., et al. Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann Intern Med 137 (2002) 571-580
24. Giannelli F., Moscarella S., Giannini C., Caini P., Monti M., Gragnani L., et al. Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation. Blood 102 (2003) 1196-1201
25. Visco C., Arcaini L., Brusamolino E., Burcheri S., Ambrosetti A., Merli M., et al. Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern Italy. Ann Oncol 17 (2006) 1434-1440
26. Groupe d'Etude des Lymphomes de l'Adulte Programs. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98. J Clin Oncol 2006; 24: 953-960.